Aprepitant (Generic for Emend)

Introducing Aprepitant formulated to the Emend standard—a high-potency neurokinin-1 receptor antagonist that effectively prevents severe nausea and vomiting by inhibiting emetic neurotransmission during intensive chemotherapy. Experience improved treatment tolerance, reduced nausea severity, and enhanced overall patient outcomes with this advanced, targeted capsule therapy.